A PHASE-II STUDY OF PIRITREXIM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引：7
|
作者：
DEGARDIN, M
DOMENGE, C
CAPPELAERE, P
LUBOINSKI, B
NAVARRETE, MS
SCOTT, JE
LEFEBVRE, JL
机构：
[1] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE
[2] SERV RECH CLIN,LAB WELLCOME,F-92442 ISSY MOULINEAUX,FRANCE
[3] WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1994年 / 30A卷 / 07期
关键词：
D O I：
10.1016/0959-8049(94)90156-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1044 / 1045
页数：2
相关论文
共 50 条
  • [31] SIMULTANEOUS RADIOTHERAPY AND CHEMOTHERAPY WITH CARBOPLATIN IN INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY
    ZAMBOGLOU, N
    ACHTERRATH, W
    SCHNABEL, T
    LENAZ, L
    KOLOTAS, C
    SCHMITT, G
    CANCER INVESTIGATION, 1992, 10 (05) : 349 - 355
  • [32] MITOGUAZONE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK ORIGIN - A PHASE-II TRIAL OF THE SOUTHEASTERN CANCER STUDY-GROUP
    LUEDKE, DW
    MADDOX, W
    BIRCH, R
    VELEZGARCIA, E
    SCHLEUTER, J
    CANCER TREATMENT REPORTS, 1986, 70 (04): : 529 - 530
  • [33] PHASE-II STUDY OF 10-EDAM IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, PREVIOUSLY UNTREATED WITH CHEMOTHERAPY
    GREEN, MD
    SHERMAN, P
    ZALCBERG, J
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (01) : 31 - 34
  • [34] A PHASE-II TRIAL OF PACLITAXEL IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH CORRELATIVE LABORATORY STUDIES
    SMITH, RE
    THORNTON, DE
    ALLEN, J
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 41 - 46
  • [35] PHASE-II TRIAL OF VP16-213 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    CLERICO, M
    BERTETTO, O
    DONGIOVANNI, V
    CALCIATI, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (05): : 577 - 577
  • [36] ACLACINOMYCIN PHASE-II EVALUATION IN ADVANCED SQUAMOUS CARCINOMA OF THE HEAD AND NECK
    KISH, JA
    ALSARRAF, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (05): : 535 - 537
  • [37] Phase II trial of cisplatin and Gemcitabine in advanced squamous-cell carcinoma of the head and neck
    Hitt, R
    Castellano, D
    Hidalgo, M
    García-Carbonero, R
    Peña, M
    Brandariz, A
    Millán, JM
    Vincent, JJA
    Cortés-Funes, H
    ANNALS OF ONCOLOGY, 1998, 9 (12) : 1347 - 1349
  • [38] PHASE-II STUDY OF A COMBINATION OF HYDROXYUREA, FLUOROURACIL AND MITOMYCIN IN PREVIOUSLY TREATED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    DODION, P
    COGNETTI, F
    VANRYMENANT, M
    DALESIO, O
    KIRKPATRICK, A
    ROZENCWEIG, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (03): : 241 - 243
  • [39] PHASE-II STUDY OF HIGH-DOSE MITOXANTRONE IN THE TREATMENT OF RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    STEWART, DJ
    CRIPPS, C
    MAROUN, JA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (04): : 307 - 309
  • [40] PHASE-II TRIAL OF CARBOPLATIN AND TEGAFUR (FTORAFUR) AS INDUCTION THERAPY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    GONZALEZBARON, M
    VICENTE, J
    MARTIN, G
    ARTAL, A
    CEBREIROS, I
    GARCIAGIRON, C
    TOMAS, M
    GAVILAN, J
    MARTORELL, V
    ZAMORA, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (04): : 277 - 279
12345